Qtron Investments’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
Other funds holding RDY
AIM
Qtron Investments's RDY Position: Q1 2025 in Review
Qtron Investments sold out of Dr. Reddy's Laboratories (RDY) in Q1 2025, closing a stake of 13,982 shares — an estimated $221K sold.
Qtron Investments first reported a position in RDY in Q4 2018 and held it in 18 quarters. The position peaked at $2.11M in Q2 2020. 244 funds tracked by Wall St. Rank hold RDY as of Q1 2025.
- Qtron Investments reported no remaining Dr. Reddy's Laboratories position as of Q1 2025 after selling out during the quarter.
- Qtron Investments sold 13,982 Dr. Reddy's Laboratories shares in Q1 2025, an estimated $221K.
- Qtron Investments first reported a position in Dr. Reddy's Laboratories in Q4 2018 and held it in 18 quarters.
- Qtron Investments's Dr. Reddy's Laboratories position peaked at $2.11M in Q2 2020.
- 244 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2025.
Based on Qtron Investments's 13F filing for Q1 2025, filed 13 May 2025.